drugset / Trial / NCT02022475

Effect of Vitamin D Treatment on Fatigue

NCT02022475

Phase 3 Completed 120 enrolled University of Zurich
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Primary objective -Change in Fatigue Assesment Score (FAS) between the first visit (baseline) and 28 (+maximum 7) days after oral administration of 100 000 E vitamin D (Cholecalciferol). Secondary objectives * Effect of oral administration of vitamin D on serum vitamin D levels (25-Hydroxy-Vitamin D = Colecalciferol), PTH, Calcium, and Phosphate as compared to placebo. * Efficacy of vitamin D (Colecalciferol) administration on fatigue using the short self-developed FCA-Test * Safety of 100 000 E oral vitamin D (Colecalciferol) administration as compared to oral placebo. Laboratoty parameters such as serum calzium and phosphate levels and the number of adverse events compared to placebo will be used for safety monitoring. * Efficacy of oral administration of vitamin D (Cholecalciferol) on plasma FGF-23, Sclerostin and Klotho levels compared to placebo.

Timeline

Start
2013-12
Primary completion
2015-05
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vitamin D Other / unclassified 100000 iu Oral

Indications